Brainstorm Cell Therapeutics Stock Buy Hold or Sell Recommendation
| BCLI Stock | USD 0.53 0.01 1.85% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Brainstorm Cell Therapeutics is 'Hold'. Macroaxis provides Brainstorm Cell buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BCLI positions. The advice algorithm takes into account all of Brainstorm Cell's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Brainstorm Cell's buy or sell advice are summarized below:
Real Value 1.72 | Target Price 5.25 | Hype Value 0.69 | Market Value 0.53 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Brainstorm Cell Therapeutics given historical horizon and risk tolerance towards Brainstorm Cell. When Macroaxis issues a 'buy' or 'sell' recommendation for Brainstorm Cell Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Brainstorm |
Execute Brainstorm Cell Buy or Sell Advice
The Brainstorm recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Brainstorm Cell Therapeutics. Macroaxis does not own or have any residual interests in Brainstorm Cell Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Brainstorm Cell's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | OK | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Brainstorm Cell Trading Alerts and Improvement Suggestions
| Brainstorm Cell Ther is way too risky over 90 days horizon | |
| Brainstorm Cell Ther has some characteristics of a very speculative penny stock | |
| Brainstorm Cell Ther appears to be risky and price may revert if volatility continues | |
| Brainstorm Cell Ther has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (17.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Brainstorm Cell Therapeutics currently holds about 12.24 M in cash with (20.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34. | |
| Brainstorm Cell Ther has a frail financial position based on the latest SEC disclosures | |
| Roughly 13.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn |
Brainstorm Cell Returns Distribution Density
The distribution of Brainstorm Cell's historical returns is an attempt to chart the uncertainty of Brainstorm Cell's future price movements. The chart of the probability distribution of Brainstorm Cell daily returns describes the distribution of returns around its average expected value. We use Brainstorm Cell Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Brainstorm Cell returns is essential to provide solid investment advice for Brainstorm Cell.
| Mean Return | 1.30 | Value At Risk | -9.09 | Potential Upside | 18.18 | Standard Deviation | 9.50 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Brainstorm Cell historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Brainstorm Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Brainstorm Cell is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Brainstorm Cell Therapeutics backward and forwards among themselves. Brainstorm Cell's institutional investor refers to the entity that pools money to purchase Brainstorm Cell's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2023-12-31 | 54.8 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 51.5 K | Wells Fargo & Co | 2023-12-31 | 29.9 K | Susquehanna International Group, Llp | 2023-12-31 | 24.8 K | Group One Trading, Lp | 2023-12-31 | 24 K | Barclays Plc | 2023-12-31 | 23.1 K | Saxony Capital Management Llc | 2023-12-31 | 21.1 K | Creative Planning Inc | 2023-12-31 | 21 K | Janney Montgomery Scott Llc | 2023-12-31 | 20.5 K | Vanguard Group Inc | 2023-12-31 | 1.4 M | Blackrock Inc | 2023-12-31 | 466.4 K |
Brainstorm Cell Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (406K) | 37.3M | (19.0M) | (18.1M) | 528K | 554.4K | |
| Free Cash Flow | (11.7M) | (35.6M) | (26.6M) | (19.3M) | (20.5M) | (19.5M) | |
| Depreciation | 164K | 219K | 260K | 285K | 265K | 261.6K | |
| Other Non Cash Items | 25K | 161K | 3.3M | (1.3M) | (3.0M) | (2.9M) | |
| Capital Expenditures | 473K | 378K | 330K | 29K | 18K | 17.1K | |
| Net Income | (23.3M) | (31.8M) | (24.5M) | (24.3M) | (17.2M) | (16.3M) | |
| End Period Cash Flow | 536K | 37.8M | 18.9M | 772K | 1.3M | 1.2M | |
| Investments | 6.1M | (4.1M) | 653K | 998K | 3.0M | 3.2M | |
| Change Receivables | (238K) | 690K | 1.5M | 335K | 385.3K | 404.5K | |
| Change To Netincome | 789K | 2.6M | 1.4M | 1.7M | 1.9M | 1.4M |
Brainstorm Cell Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Brainstorm Cell or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Brainstorm Cell's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Brainstorm stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 1.14 | |
β | Beta against NYSE Composite | 1.91 | |
σ | Overall volatility | 9.63 | |
Ir | Information ratio | 0.13 |
Brainstorm Cell Volatility Alert
Brainstorm Cell Therapeutics is displaying above-average volatility over the selected time horizon. Brainstorm Cell Therapeutics is a potential penny stock. Although Brainstorm Cell may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Brainstorm Cell Therapeutics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Brainstorm instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Brainstorm Cell Fundamentals Vs Peers
Comparing Brainstorm Cell's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Brainstorm Cell's direct or indirect competition across all of the common fundamentals between Brainstorm Cell and the related equities. This way, we can detect undervalued stocks with similar characteristics as Brainstorm Cell or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Brainstorm Cell's fundamental indicators could also be used in its relative valuation, which is a method of valuing Brainstorm Cell by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Brainstorm Cell to competition |
| Fundamentals | Brainstorm Cell | Peer Average |
| Return On Equity | -11.22 | -0.31 |
| Return On Asset | -2.12 | -0.14 |
| Current Valuation | 36.89 M | 16.62 B |
| Shares Outstanding | 68.34 M | 571.82 M |
| Shares Owned By Insiders | 12.80 % | 10.09 % |
| Shares Owned By Institutions | 6.00 % | 39.21 % |
| Number Of Shares Shorted | 1.34 M | 4.71 M |
| Price To Earning | (16.00) X | 28.72 X |
| Price To Book | 65.82 X | 9.51 X |
| EBITDA | (21.17 M) | 3.9 B |
| Net Income | (17.19 M) | 570.98 M |
| Cash And Equivalents | 12.24 M | 2.7 B |
| Cash Per Share | 0.34 X | 5.01 X |
| Total Debt | 1.27 M | 5.32 B |
| Debt To Equity | 0.60 % | 48.70 % |
| Current Ratio | 1.63 X | 2.16 X |
| Book Value Per Share | (0.08) X | 1.93 K |
| Cash Flow From Operations | (20.46 M) | 971.22 M |
| Short Ratio | 1.19 X | 4.00 X |
| Earnings Per Share | (0.40) X | 3.12 X |
| Target Price | 2.5 | |
| Number Of Employees | 29 | 18.84 K |
| Beta | 0.29 | -0.15 |
| Market Capitalization | 36.91 M | 19.03 B |
| Total Asset | 4.21 M | 29.47 B |
| Retained Earnings | (215.01 M) | 9.33 B |
| Working Capital | (5.69 M) | 1.48 B |
| Current Asset | 16.79 M | 9.34 B |
| Current Liabilities | 2.95 M | 7.9 B |
| Net Asset | 4.21 M |
Note: Acquisition by Stacy Lindborg of 100000 shares of Brainstorm Cell at 7.67 subject to Rule 16b-3 [view details]
Brainstorm Cell Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Brainstorm . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 15153.48 | |||
| Daily Balance Of Power | (0.20) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 0.54 | |||
| Day Typical Price | 0.53 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
About Brainstorm Cell Buy or Sell Advice
When is the right time to buy or sell Brainstorm Cell Therapeutics? Buying financial instruments such as Brainstorm Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 5.1M | 4.1M | 1.3M | 1.9M | Total Assets | 29.3M | 8.5M | 4.2M | 4.0M |
Use Investing Ideas to Build Portfolios
In addition to having Brainstorm Cell in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Technology Thematic Idea Now
Technology
Companies that are involved in development or distribution of technologically based goods and services such as software, IT or electronics. The Technology theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Technology Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Brainstorm Cell Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Brainstorm Stock analysis
When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Brainstorm Cell's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainstorm Cell. If investors know Brainstorm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.40) | Return On Assets (2.12) | Return On Equity (11.22) |
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainstorm Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainstorm Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainstorm Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.